Core Scientific, Inc./tx - 8-K Filing
Core Scientific reported Q2 revenue of $164.2M with a net loss driven by warrant valuation changes (Items: 2.02 Results of Operations and Financial ConditionOn July 28, 2026, the Company issued a press release announcing its financial results for the se, 7.01 Regulation FD DisclosureThe information contained in Item 2, 9.01 Financial Statement and Exhibits(d) Exhibits: ExhibitNo)
Tickers: $CORZ